RxDoctor Payments Data

Rachele Dambrosio, NP

Adult Health · Nesconset, NYNPI 1285333435

Payments from drug & device makers

$485in general payments, 2019–2025

Across 17 payments — averaging $28.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$121
  • Novo Nordisk$107
  • Inspire Medical Systems, Inc.$54
  • Lilly USA, LLC$42
  • GSK$39
  • AstraZeneca$38
  • plus $84 from 4 others

What the payments were for

  • Food & beverage$485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$485 in reported general payments places this provider in the 55th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$66,427
Medicare patients
241
Services billed
736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate30$810
Escitalopram Oxalate28$634
Metoprolol Succinate26$569
Atorvastatin Calcium49$457
Rosuvastatin Calcium36$351
Ezetimibe11$327
Levothyroxine Sodium26$326
Omeprazole21$299
Pantoprazole Sodium12$254
Lisinopril35$226
Amlodipine Besylate39$198
Losartan Potassium24$154
Metformin Hcl19$137
Pravastatin Sodium11$114
Azithromycin20$97

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$18$8320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,828 adult health providers in New York.

Other adult health in Nesconset

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →